DFCM
AERI

Dark Forest Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Dark Forest Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,390
Closed -$38K – 1962
2021
Q4 		$38K Buy
5,390
+4,124
+326% +$43.2K 0.01% 502
2021
Q3 		$14K Buy
+1,266
New +$18.5K 0.01% 923

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dark Forest Capital Management's AERI Position: Q1 2022 in Review

Dark Forest Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2022, closing a stake of 5,390 shares — an estimated $38K sold.

Dark Forest Capital Management first reported a position in AERI in Q3 2021 and held it in 2 quarters. The position peaked at $38K in Q4 2021. 136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

  • Dark Forest Capital Management reported no remaining Aerie Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 5,390 Aerie Pharmaceuticals shares in Q1 2022, an estimated $38K.
  • Dark Forest Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Dark Forest Capital Management's Aerie Pharmaceuticals position peaked at $38K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on Dark Forest Capital Management's 13F filing for Q1 2022, filed 13 May 2022.